Insider trade

X4 Pharmaceuticals (XFOR): Chair bought ~$12K

Adam R Craig, Chair at X4 Pharmaceuticals, bought ~$12K of X4 Pharmaceuticals shares.

~$12K
Approx. value · 4,600 sh @ $2.58: 333K
Holds after · shares reported

Traded: Oct 16, 2026
Filed: Oct 19, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Oct 1, 2026InsiderCFO sold ~$34K of XFOR shares in the open market
Oct 7, 2026Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 3 more items)
Oct 7, 20265% stakeFMR LLC reported a passive stake (13G) of 4.6%
Oct 16, 2026 · this disclosureInsiderChair purchased ~$12K of XFOR shares in the open market

What came next

Nov 13, 20265% stakeCoastlands Capital LP reported a passive stake (13G) of 10.0%

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for X4 Pharmaceuticals

For X4 Pharmaceuticals, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its XFOR page.

Other recent filings by Adam R Craig, Executive Chairman

The full history of Adam R Craig, Executive Chairman is on the profile page.

How this filing works

Explore the data

Other disclosures at X4 Pharmaceuticals

Everything OQRO holds on this company is on its XFOR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data